Skip to content
  • Sunday, 16 August 2026
  • 3:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.
Laboratory Automation & Robotics

Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.

Lana Keisha May 28, 2026 0

After a period of post-pandemic uncertainty and uneven growth, a closely monitored metric of biopharmaceutical research and development (R&D) productivity…

Read More
Laboratory Automation & Robotics

Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.

Lana Keisha May 14, 2026 0

The pharmaceutical industry, emerging from a period characterized by uneven growth and significant challenges in research and development (R&D) productivity,…

Read More
The Naked Mole Rat’s Secret to Longevity: A Gene Transfer Breakthrough Offers Hope for Healthier Aging in MammalsVoro Therapeutics and Alloy Therapeutics Forge Strategic Partnership to Revolutionize Tumour-Selective T-Cell Engager TherapiesThe Fluid Dynamics of Strength: How Water Flow and Odd Elasticity Define the Limits of Muscle PerformanceBrain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ